Zal Bilimoria - Profile and Investment Details

Investor Profile

Zal Bilimoria is a Venture Capital, Private Equity Firm, Angel/Individual based in Burlingame, California, United States with a diverse investment portfolio that includes companies such as Kip, Screendoor, Trace Genomics, Pluto AI, PicnicHealth, Headspace, FactoryFour, Cofactor Genomics, Able Health, Missionmark, The LongTerm Stock Exchange, Verge Genomics, Astranis, Omada Health, RenewEnzyme, Notable Labs, Solugen, PathAI, Clover Health, Call9, Alloy, Orchid, Shield Diagnostics, Finova Financial, . Over time, Zal Bilimoria has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Zal Bilimoria is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Nuclear Energy, Wellness, Satellite Manufacturing, Enterprise Software, Fundraising, Transportation, Energy, Angel Investment, Chemical, Engineering, Portfolio Management, Education, Robotics, Software, Manufacturing, Biotechnology, Consumer Health, Clean Technology, Electronic Health Records (EHR), Health and Hospital Services, Productivity Software, Energy Tech, Innovation, FinTech, US-based Startups, Agriculture, Consulting, Satellite Communications, Logistics, UK Startups, Utilities, SaaS, Information Technology, B2B, Media and Entertainment, Air Transportation, Hardware Tech may find it worthwhile to explore potential connections with Zal Bilimoria, as their portfolio suggests a familiarity and interest in this area.

Understanding Zal Bilimoria’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.